What infections can Serratia marcescens cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infections Caused by Serratia marcescens

Serratia marcescens is an opportunistic pathogen that causes a wide range of infections including bloodstream infections, pneumonia, urinary tract infections, endocarditis, skin and soft tissue infections, and ocular infections.

Common Infections Caused by S. marcescens

Respiratory Tract Infections

  • S. marcescens is a significant cause of nosocomial pneumonia, particularly in ventilated patients and intensive care settings 1
  • It ranks among the common gram-negative pathogens causing hospital-acquired pneumonia, following Pseudomonas aeruginosa, Klebsiella species, and Enterobacter species 1

Bloodstream Infections

  • S. marcescens frequently causes bacteremia and bloodstream infections, especially in immunocompromised patients 2, 3
  • These infections can progress to endotoxin shock and multiple organ failure due to its gram-negative nature 3
  • Bloodstream infections have a high mortality rate, with studies showing attributable mortality rates of up to 60% in neonates 4

Endocarditis

  • Though rare, S. marcescens can cause infective endocarditis with high mortality (47.2%) 5
  • The mitral valve is most commonly affected, followed by the aortic valve 5
  • Endocarditis caused by S. marcescens is associated with intravenous drug use and has higher rates of heart failure and embolic phenomena compared to other gram-negative bacterial endocarditis 5
  • Cardiac surgery combined with prolonged antibiotic therapy is often necessary for treatment 6

Ocular Infections

  • S. marcescens can cause keratitis and conjunctivitis, particularly in healthcare settings 2
  • It is listed as a causative agent of endophthalmitis 1

Urinary Tract Infections

  • S. marcescens is a recognized cause of urinary tract infections 7, 2
  • The FDA has approved ciprofloxacin for treating urinary tract infections caused by S. marcescens 7

Skin and Soft Tissue Infections

  • S. marcescens can cause wound infections and necrotizing soft tissue infections 6, 2
  • Bone and joint infections can also be caused by this organism 7

Neonatal Infections

  • S. marcescens is particularly problematic in neonatal intensive care units (NICUs) 2, 4
  • In neonates, it can cause sepsis, pneumonia, meningitis, and gastrointestinal infections 2
  • Outbreaks in NICUs have been reported with significant morbidity and mortality 4

Transmission and Risk Factors

  • Healthcare-associated transmission often occurs via contaminated hands of healthcare workers 2, 4
  • Environmental sources include contaminated water, sinks, antiseptics, and medical equipment 2, 3
  • Risk factors include immunocompromise, critical illness, invasive procedures, and prolonged hospitalization 2
  • Colonization of the respiratory and gastrointestinal tracts can lead to subsequent infection 2

Antimicrobial Resistance and Treatment

  • S. marcescens has intrinsic resistance to several antibiotic classes and can develop multidrug resistance 2
  • It possesses an inducible AmpC β-lactamase that can confer resistance to many β-lactam antibiotics 1
  • Plasmid-mediated metallo-β-lactamases (such as IMP-type enzymes) can cause carbapenem resistance 1
  • Treatment options include:
    • Extended-spectrum cephalosporins (e.g., ceftriaxone) 6, 8
    • Fluoroquinolones (e.g., ciprofloxacin) for susceptible strains 7
    • Carbapenems for serious infections 6
    • Aminoglycosides, often used in combination therapy 6, 5

Prevention and Control

  • Early identification of colonized or infected patients is crucial 2
  • Rigorous hand hygiene and contact precautions are essential control measures 2
  • Environmental cleaning, particularly of water sources and sinks 2, 4
  • Proper management of antiseptics and medical equipment 3
  • Surveillance cultures may be useful during outbreaks 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serratia marcescens Infections in Neonatal Intensive Care Units (NICUs).

International journal of environmental research and public health, 2019

Research

[Serratia].

Nihon rinsho. Japanese journal of clinical medicine, 2002

Research

Infective endocarditis by Serratia species: a systematic review.

Journal of chemotherapy (Florence, Italy), 2022

Guideline

Treatment of Serratia marcescens Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.